evolut plasmid vivo strain staphylococcu aureu strain staphylococcu aureu far4 isol patient frequent interv 18 month strain previous shown lose resist sever antibodi lacey et al 1973 last 6 month chang occur vivo lincomycin resist appear patient treat clindamycin due mutat constitut resist lincomycin erythromycin locu adjac determin induc resist erythromycin loci probabl carri extrachromosom element three type variat pf plasmid observ alter product penicillinas macroconstitut microconstitut associ detect chang plasmid size chang gave cell advantag vitro associ faster growth rate probabl also vivo microconstitut variant isol increas number flucloxacillin therapi ceas complet loss determin penicillinas product resist cadmium ion pf plasmid associ decreas plasmid size 4 x 10 6 dalton chang also associ increas growth rate vitro loss resist fusid acid pf plasmid associ decreas plasmid size 1 x 10 6 dalton